Irving Ford on leading Adaptimmune through FDA approval and commercialisation of their T cell therapy, Tecelra.
We are back for Season Two of Lets Talk Quality!This week, I had the pleasure of speaking with Irving Ford, VP of Quality at Adaptimmune Therapeutics. Irving has been through the commercialisation of...
4 Sep 202437min
Joe Franchetti, on his vision for the Society of Quality Assurance (SQA)
Joe Franchetti, President of the Society of Quality Assurance (SQA), shares his vision for the SQA and the wider quality assurance industry, emphasizing the importance of collaboration and expanding r...
13 Mars 202438min
Laurie Adami on how CAR-T cell therapy saved her life
This is very special episode. I was joined by Laurie Adami, a financial services exec who was forced to give up her career after a cancer diagnosis in 2006. After a 12 year battle fighting follicular ...
22 Feb 20241h 2min
Kimberly Wallbank on how to transition into the world of contracting
In this conversation, Kimberly Wallbank, a quality systems consultant in the pharma & biotech industry, shares her insights and experiences in the world of contracting. She discusses the changes in th...
15 Feb 202431min
Stan Russell on how to create a value-adding quality function.
This week I speak with Stan Russell, who explains how quality leaders can create a function that adds true value to an organisation.Stan provides practical advice for leaders to change perceptions and...
7 Feb 202438min
Vaishali Shukla on Quality Oversight in Global Pharmaceutical Operations
This week I was joined by Vaishali Shukla, VP of Global Quality Manufacturing at Kite Pharma."Act locally but think globally”. This is the mindset that Vaishali has helped instil in her role to help h...
30 Jan 202427min
Greg Furrow on the risks of trusting 'expert opinions'.
As a biotech professional, how do you know that the questions you ask 'experts' are accurate?Is the answer based on explicit regulations? Or is it based on personal opinion, which has been formed by h...
20 Dec 202333min
Jason Treese on leading the commercialisation of BMS' first approved cell therapies
This is a story about the journey of commercialization for BMS' first cell therapies approved for the treatment of blood cancer.Jason 'Jake' Treese, played a critical role in the development, approval...
7 Dec 202345min
